In this study we demonstrated that the IGF2/IR-A axis elicits significant effects on metabolic reprogramming of human BC cells where it increases both glycolysis and OxPhos not only in basal conditions but also in high energy conditions demand, thereby increasing cancer cell metabolic flexibility, a key feature of malignant cells during adaptation to a changing microenvironment. This evidence concerns the gene IGF2 and breast cancer.